Business Wire

BEHAVOX

18.5.2022 15:51:04 CEST | Business Wire | Pressemeddelelse

Del
Behavox-forskning i kontinuerlig læring med på International Conference on Acoustics, Speech and Signal Processing (ICASSP)

Behavox , som udbyder en række sikkerhedsprodukter, der hjælper compliance-, HR- og sikkerhedsafdelingerne med at beskytte deres virksomhed og kolleger mod ondsindede aktører, fortæller i dag, at dens akademiske forskningsdokument om kunstig intelligens "kontinuerlig læring med lattice-fri MMI til stemmegenkendelse" er blevet accepteret af International Conference on Acoustics, Speech, and Signal Processing (ICASSP). ICASSP er verdens største og mest omfattende tekniske konference med fokus på signalbehandling og tilhørende anvendelse. Behavox præsenterede den 9. maj 2022 dette dokument i Singapore for IEEE ICASSP 2022 .

"Nogle gange forsker videnskabsfolk for videnskabens skyld, og samfundet oplever ikke nogen umiddelbare fordele af forskningen. Vi har derimod skubbet videnskaben til en ny grænse for at finde en løsning på et aktuelt problem," siger Behavox's CTO Joseph Benjamin. "Vi er beærede over at have modtaget anerkendelse fra en så prestigefyldt konference og er meget stolte af vores team og det arbejde, folkene har udført."

Dokumentet, der er forfattet af Behavox's maskinlæringsteam, ser på udfordringerne i forbindelse med løbende forbedring af stemmegenkendelsessystemer i miljøer, der kræver beskyttelse af personoplysninger. Vores forskning har direkte forbindelse til Behavox's FoU-tilgang, der giver kunderne den bedste transskriptionskvalitet på det finansielle marked. I FinTech sker der hele tiden ændringer i det sprog og de data, som Behavox-systemerne hurtigt og pålideligt skal behandle, og stigningen i kryptovalutaer og videokommunikation er blot to eksempler.

Derfor skal maskinlæringsmodeller jævnligt opdateres med relevante data. For at gøre sådanne opdateringer mulige, uden at sætte databeskyttelsen over styr, skal modellen gradvist kunne forbedres i sikre klientmiljøer uden adgang til historiske data og data fra andre kunder. Dette er en alvorlig udfordring inden for maskinlæring på grund af den katastrofale glemsomhed, hvor modellen, efter at have forbedret en bestemt type data, begynder at præstere dårligt på tidligere lærte data.

ICASSP-dokumentet fra Behavox bidrager til den fortsatte læring til brug ved stemmegenkendelse. Forfatterne foreslår en ny algoritme, der udvider og forfiner den almindeligt anvendte LWF-teknik (Learning Without Forgetting), der er afhængig af en regulariseringsterm og tvinger neurale netværk til at mindske glemsomhed. Mere specifikt designede forfatterne en nyhed i form af neurale netværk med indlæring af tab på sekvensniveau, der kan bruges i stedet for den konventionelle, punktvise LWF. De viste en betydelig reduktion i glemsomhed, når man finjusterede det neurale netværk sekventielt efter forskellige accenter- og taleformer.

Behavox har konstateret, at brugen af stemmeplatforme med årene er steget 94 procent, og at næsten en tredjedel af al kommunikation på arbejdspladsen i gennemsnit foregår som telefonmøder eller videokonferencer.

Denne teknik er allerede blevet anvendt med succes på dets danske system, hvor samarbejdet mellem Behavox's lingvister, maskinlæringsteamet og en kunde gav Behavox mulighed for at opbygge sit første danske transskriptionssystem, der arbejder pålideligt med bankdata.

Om Behavox

Behovox udbyder en række sikkerhedsprodukter, der hjælper compliance-, HR- og sikkerhedsafdelingerne med at beskytte deres virksomhed og kolleger mod ondsindede aktører.

Med AI-baseret analyse af alle virksomhedens kommunikationsdata, herunder e-mail, chat, telefonmøde- og videokonferenceplatforme, hjælper Behavox virksomhederne med at identificere ulovlig, umoralsk og skadelig adfærd på arbejdspladsen.

Behavox, der blev grundlagt i 2014, har hovedkvarter i Montreal og kontorer i New York, London, Seattle, Singapore og Tokyo.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission

KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press release

KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige

HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release

The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689

Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release

Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release

The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye